Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.
Satoshi KobayashiTaito FukushimaMakoto UenoMakoto ChumaKazushi NumataKota TsuruyaYoshitaka AraseShunji HiroseTatehiro KagawaNobuhiro HattoriTsunamasa WatanabeKotaro MatsunagaHaruki UojimaHisashi HidakaChika KusanoManabu MorimotoShin MaedaPublished in: Liver international : official journal of the International Association for the Study of the Liver (2024)
BCLCp-B1 stage was identified as a better prognostic factor for PPS following ATZ + BEV treatment compared with BCLCp-C1 and BCLCp-C2 stages. This may help in making decisions regarding subsequent treatment after ATZ + BEV.
Keyphrases